QuidelOrtho (QDEL) Q2 Earnings Miss, Provides FY22 View

Published on 5 Aug 2022 on Zacks via Yahoo Finance

QuidelOrtho (QDEL) Q2 Earnings Miss, Provides FY22 View

QuidelOrtho Corporation QDEL delivered adjusted earnings per share (EPS) of $2.12 in the second quarter of 2022, up by a huge 123.2% year over year. The figure missed the Zacks Consensus Estimate by 42.6%.

The adjustments include expenses related to amortization of intangibles, and acquisition and integration costs, among others.

GAAP EPS for the quarter was 36 cents, reflecting a 20% decline from the year-earlier figure.

Read the rest of the article

NASDAQ.QDEL price evolution

NYSE.DGX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Why Quest Diagnostics Incorporated (DGX) Is One of the Most Undervalued Pot...

We recently published a list of 8 Most Undervalued Pot Stocks to Buy According to Analysts. In th...

Insider Monkey · via Yahoo Finance 28 Nov 2024

Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Quest Diagnostics (DGX). Shares have added...

Zacks · via Yahoo Finance 21 Nov 2024

INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up

Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sal...

Zacks 10 Nov 2024

AMN Stock Falls Despite Q3 Earnings & Revenues Beat, Margins Contract

AMN Healthcare's dismal results in the majority of its segments led to a soft overall third-quart...

Zacks 8 Nov 2024

BDX Stock Gains Following Q4 Earnings Beat and Higher Margins

BD's overall topline in the fourth quarter of fiscal 2024 benefits from revenue growth in all...

Zacks 7 Nov 2024

CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised

Clover Health's third-quarter 2024 results continue to benefit from the strength of its business...

Zacks 7 Nov 2024

Veracyte Q3 Earnings Beat Estimates, 2024 Guidance Raised

VCYT registers robust growth from its market-leading Decipher Prostate and Afirma tests.

Zacks 6 Nov 2024

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Free Report) delivered an earnings per share (EPS) of 60 cents in third-quarter 2024 against the...

Zacks 4 Nov 2024

Is Quest Diagnostics Incorporated (DGX) an Undervalued High Growth Stock?

Fiduciary Management Inc. (FMI), an independent money management firm, released its second quarte...

Insider Monkey · via Yahoo Finance 23 Jul 2024

Is Quest Diagnostics Incorporated's (NYSE:DGX) Recent Stock Performance Influenced By Its...

Quest Diagnostics (NYSE:DGX) has had a great run on the share market with its stock up by a signi...

Simply Wall St. via Yahoo Finance 23 May 2024

News

QuidelOrtho (QDEL) Q2 Earnings Miss, Provides FY22 View

NASDAQ.QDEL price evolution

NYSE.DGX price evolution

Want to become a better investor?